Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Artigo
|
![]() |
Phase 1 trial of the antiangiogenic peptide ATN-161 (Ac-PHSCN-NH ), a beta integrin antagonist, in patients with solid tumoursCianfrocca, M E ; Kimmel, K A ; Gallo, J ; Cardoso, T ; Brown, M M ; Hudes, G ; Lewis, N ; Weiner, L ; Lam, G N ; Brown, S C ; Shaw, D E ; Mazar, A P ; Cohen, R BBritish journal of cancer, 2006-06, Vol.94 (11), p.1621-1626 [Periódico revisado por pares]England: Nature Publishing GroupTexto completo disponível |
2 |
Material Type: Artigo
|
![]() |
Identification of biomarkers for the antiangiogenic and antitumour activity of the superoxide dismutase 1 (SOD1) inhibitor tetrathiomolybdate (ATN-224)Doñate, F ; Juarez, J C ; Burnett, M E ; Manuia, M M ; Guan, X ; Shaw, D E ; Smith, E L P ; Timucin, C ; Braunstein, M J ; Batuman, O A ; Mazar, A PBritish journal of cancer, 2008-02, Vol.98 (4), p.776-783 [Periódico revisado por pares]England: Nature Publishing GroupTexto completo disponível |
3 |
Material Type: Artigo
|
![]() |
Identification of biomarkers for the antiangiogenic and antitumour activity of the superoxide dismutase I (SOD I) inhibitor tetrathiomolybdate (ATN-224)DONATE, F ; JUAREZ, J. C ; MAZAR, A. P ; BURNETT, M. E ; MANUIA, M. M ; GUAN, X ; SHAW, D. E ; SMITH, E. L. P ; TIMUCIN, C ; BRAUNSTEIN, M. J ; BATUMAN, O. ABritish journal of cancer, 2008, Vol.98 (4), p.776-783 [Periódico revisado por pares]Basingstoke: Nature Publishing GroupTexto completo disponível |
4 |
Material Type: Artigo
|
![]() |
Phase I trial of the antiangiogenic peptide ATN-161 (Ac-PHSCN-NH2), a beta integrin antagonist, in patients with solid tumoursCIANFROCCA, M. E ; KIMMEL, K. A ; SHAW, D. E ; MAZAR, A. P ; COHEN, R. B ; GALLO, J ; CARDOSO, T ; BROWN, M. M ; HUDES, G ; LEWIS, N ; WEINER, L ; LAM, G. N ; BROWN, S. CBritish journal of cancer, 2006, Vol.94 (11), p.1621-1626 [Periódico revisado por pares]Basingstoke: Nature Publishing GroupTexto completo disponível |